|
bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study. |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Merck; Novartis; Takeda |
Research Funding - AstraZeneca (Inst) |
|
|
Research Funding - Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Novartis (Inst); poseida therapeutics (Inst); Takeda (Inst); Teva (Inst) |
|
|
Consulting or Advisory Role - Celgene; Juno Therapeutics; Kite, a Gilead company; Novartis |
Research Funding - Janssen |
|
|
Stock and Other Ownership Interests - OncoPep |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Merck; OncoPep; Pfizer; Takeda |
Patents, Royalties, Other Intellectual Property - OncoPep |
|
David Samuel DiCapua Siegel |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda |
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda |
Research Funding - Celgene (Inst) |
|
|
Honoraria - Amgen; Pfizer; Prothena |
Consulting or Advisory Role - Amgen; Caelum Biosciences; Pfizer; Prothena; Takeda |
Research Funding - Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Pfizer (Inst); Prothena (Inst); Takeda (Inst) |
|
|
Honoraria - Celgene; Karyopharm Therapeutics |
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis |
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Adaptive Biotechnologies; Agenus; Bluebird Bio; Cell Design Labs; Cellectis; Intellia Therapeutics; Neon Therapeutics; Precision Therapeutics; TCR2 Therapeutics; Unum Therapeutics; windmil |
Research Funding - Agenus; crispr therapeutics; Kyn therapeutics; TCR2 Therapeutics; unum therapeutics |
Patents, Royalties, Other Intellectual Property - Inventor on patents held by U. Pennsylvania with and without Novartis |
|
|
Employment - Bluebird Bio |
Stock and Other Ownership Interests - Bluebird Bio |
Research Funding - Bluebird Bio |
|
|
Employment - Bluebird Bio |
Stock and Other Ownership Interests - Bluebird Bio |
|
|
Employment - Bluebird Bio |
Stock and Other Ownership Interests - Bluebird Bio |
Patents, Royalties, Other Intellectual Property - Bluebird Bio |
|
|
Employment - Bluebird Bio |
Stock and Other Ownership Interests - Bluebird Bio |
Patents, Royalties, Other Intellectual Property - Bluebird Bio |
|
|
Employment - Bluebird Bio |
Stock and Other Ownership Interests - Bluebird Bio |
Consulting or Advisory Role - Bluebird Bio (I); Corbus Pharmaceuticals (I) |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
No Relationships to Disclose |
|
|
Research Funding - Bluebird Bio; Kite, a Gilead company |
Patents, Royalties, Other Intellectual Property - Bluebird Bio; Kite, a Gilead company |